
GI haemorrhage, pneumonia and C.diff seem to be more frequent in those on PPIs, rather than H2 blockers, in this cohort study done over 5 years in 71 hospitals.

GI haemorrhage, pneumonia and C.diff seem to be more frequent in those on PPIs, rather than H2 blockers, in this cohort study done over 5 years in 71 hospitals.